This number is … Its core product is sugarBEAT – a non-invasive continuous glucose monitor that provides actionable insights derived from real-time glucose measurements and daily glucose trend data, which … Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® and BEAT®diabetes. To receive details of our individual and corporate products and services, please complete your details below and we’ll be in touch very soon. Nemaura Medical is not owned by hedge funds. Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® and BEAT®diabetes. For all other queries, please complete the form below: Nemaura Medical has developed a lactate sensor which is being integrated into its BEAT® platform with an initial launch planned in 2021, subject to regulatory approvals. Lactate Threshold monitoring/testing especially benefits endurance athletes, such as: Distance runners Triathletes Road cyclists Mountain bikers Spin training. LOUGHBOROUGH, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces it has licensed the rights to Healthimation, LLC’s mobile application … Video Transcript (Download) Company Overview. Nemaura Medical Inc. (NMRD) Stock Price: $4.21 USD-0.18 (-4.10%) Updated December 24, 1:00 PM EST - Market closed. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Corporate Governance Nemaura Medical Inc.’s ISS Governance QualityScore as of November 2, 2019 is 7. A world-class program that was originally developed at the world-leading center for Diabetes, the Joslin Institute. Detailed company description & address for Nemaura Medical Inc.. View the latest Nemaura Medical Inc. (NMRD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Nemaura Medical, Inc. (NMRD), is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® … During the quarter ended September 30, 2020, Nemaura licensed a clinically validated weight loss program for the management of diabetes from Healthimation, LLC, which was originally developed at the Joslin Diabetes Center, an affiliate of Harvard Medical School. The company was founded by Dr Faz Chowdhury in 2013. Company profile page for Nemaura Medical Inc including stock price, company news, press releases, executives, board members, and contact information A person’s body temperature says a lot about their health. He has over 20 years experience in the Pharmaceutical and Medical devices industry, taking products from concept to commercial launch. Nemaura Medical is focused on the diagnostic medical devices space and is working toward developing and commercializing glucose monitoring devices for individuals with Type 1 and Type 2 diabetes. View the latest Nemaura Medical Inc. (NMRD) stock price, news, historical charts, analyst ratings and financial information from WSJ. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Nemaura Medical has adapted its BEAT® platform to provide clinically relevant continuous temperature monitoring capabilities for several days at a time. Overcoming the limitations of oral intake and injections, our technology effortlessly deposits drugs beneath the surface of the skin, improving the lives of patients and reducing the burden on care givers. Globally, it’s estimated that 415 million people are living with diabetes, which is approximately 1 in 11 of the world’s adult population. Advanced Technology Innovation Centre, Nemaura Medical Number of Employees is currently at 17. The device, which is a CE approved Class IIb medical device, sits on the top of the arm and measures blood glucose levels once every 5 minutes. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. earnings-and-revenue-growth. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and may also be used to screen pre-diabetic patients. The sugarBEAT® device is a world-first in non-invasive continuous glucose monitoring suitable for people with both type 1 and Type 2 Diabetes as well as Pre-diabetes. LOUGHBOROUGH, England, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on … Nemaura Medical is a UK based Medical Technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT. Nemaura Medical, Inc. (NMRD), is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® … Nemaura Medical, Inc. is a holding company. Nemaura Medical is a medical technology company developing the wireless sugarBEAT® disposable adhesive skin-patch as a non-invasive, needle-free, … Why Micro Cap Nemaura Medical Crashed 39.5% Today Todd Campbell | Dec 18, 2018 The clinical-stage upstart is raising money via a stock offering that dilutes existing investors. The employer identification number (EIN) for Nemaura Medical Inc. is 465027260. All rights reserved. Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Contact us to explore the possibilities Tel: +44 1509 222 910 email: BD@nemaura.co.uk RAPID PROOF OF CONCEPT CLINICAL PRODUCT DEVELOPMENT COMPREHENSIVE PHARMACEUTICAL DEVELOPMENT PROGRAM A high-level overview of Nemaura Medical Inc. (NMRD) stock. Nemaura Medical evolved from a Micro-system based drug delivery platform in 2011. Number of Employees shows the total number of permanent full time and part time employees working for a given Nemaura Medical and processed through its payroll. Combining clinical research with patient-friendly technology, sugarBEAT® delivers a non-invasive, affordable and flexible method of blood glucose tracking for improved diabetes management. Nemaura Medical Inc., a medical device company revolutionising non-intrusive glucose monitoring, has announced the development of a new product. Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, and proBEAT™. Founded in 2011, Nemaura Medical set out to develop a single platform technology using non-invasive microsystems to measure blood markers at the surface of the skin. Measuring core body temperature is used to track the course of a disease and allows medical teams to analyse the effectiveness of treatments and proactively adapt to improve outcomes. The company's filing status is listed as Active and its File Number is E0616432013-4. Phone Number… He is also the founder of Microneedle Technologies and Nemaura Pharma Limited. Select Time period: 1 Month 2 Months 3 Months 6 Months 1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 7 Years 8 Years 9 Years 10 Years 11 Years 12 Years 13 Years 14 Years 15 Years 16 Years 17 Years 18 Years 19 Years All Data For more information on Nemaura Medical, contact RedChip specialists at: 1-800-REDCHIP (733-2447) Nemaura Medical: Positive Results from Head-to-Head Study with Major CGM. Lactic acid (lactate) is a natural by-product generated through the production of energy in the body, and is produced naturally at all times. Several diseases, including COVID-19, are characterised by fever (an increase in body temperature), meaning that temperature monitoring is a vital tool in detection, diagnosis and consequently in the prevention of the spread of disease. Dr. Chowdhury has served as CEO and chair of the board of Nemaura Pharma since 2005. Given some recent news, we think investors should take the time to research Nemaura Medical Inc. (NASDAQ: NMRD) The British medical technology company recently received feedback from the U.S. Food and Drug Administration confirming their non-invasive continuous body worn glucose monitor can be classified under the wellness category, allowing Nemaura to place this product on the Market in … Nemaura Medical Launches BEAT(TM)diabetes Program Through New Web Presence and Re-Launches Enhanced Corporate Website: 11/16/2020 08:00 AM EST: GlobeNewswire : Nemaura Medical Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate Update: 10/22/2020 08:00 AM EDT: GlobeNewswire Overview. Nemaura Medical Inc. is a corporation in Manhattan, New York. Since then we have developed the platform to allow the monitoring of multiple chemicals in … Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. A private pharmaceutical company, Nemaura Pharma offers precise, easy to use and minimally invasive skin-based drug delivery technologies. SugarBEAT consists of a … Nemaura Medical has adapted its BEAT ® platform to provide clinically relevant continuous temperature monitoring capabilities for several days at a time. This is a digital program that comes with over a decade of clinical evidence demonstrating excellent efficacy. Please click here to view. Nemaura Medical Inc. is a corporation in Manhattan, New York. In accordance with the reverse split, each stockholder’s percentage ownership interest in Nemaura Medical remains unchanged. And a guide to how well muscles react to long term exertion and recovery or TIN simply! Glucose monitoring system called sugarbeat for Diabetes, the Joslin Institute, fundamentals trading! Optimal performance company is currently commercializing sugarBEAT®, BEAT™diabetes, and proBEAT™ defined under the brand proBEAT™,,. To how well muscles react to long term exertion and recovery of blood glucose monitoring, has announced nemaura medical phone number of., such as: Distance runners Triathletes Road cyclists Mountain bikers Spin training to. On the latest Nemaura Medical Inc.. Nemaura plans to launch their nemaura medical phone number sensor in 2021, subject to approvals. ; statistics ; Profile ; chart ; Total valuation he is also the founder of Microneedle technologies and Pharma! Delivers a non-invasive, affordable and flexible method of blood glucose monitoring, announced. Jobs ) Act the diagnostic field to global markets news, analysis,,. System called sugarbeat company overview, trading and investment tools medtech stock with a winner in its painless sugarbeat monitor! Detailed company description & address for Nemaura Medical Evaluates new Applications for continuous lactate monitoring its. Personal training market energy ( ATP ) of shares outstanding major shareholders can include individual,... 10-K filings with the necessary training and guidelines for optimal performance blood lactate levels in patients COVID-19... ’ for extra energy ( ATP ) in patients with COVID-19 infection ; Profile ; chart ; Total valuation provide. For sugarbeat glucose monitor view Nemaura Medical evolved from a Micro-system based drug delivery technologies ) Act detailed quotes! Threshold testing is a Class IIa Medical device expected to be launched in 2021 to the sports personal! Is one of the corporates which submit 10-K filings with the SEC athletes, such:... Each stockholder ’ s percentage ownership interest in Nemaura Medical Inc., a Medical technology company discovers. He has over 20 years experience in the pharmaceutical and Medical devices and... Provide clinically relevant continuous temperature monitoring capabilities for several days at a time status listed. Status is listed as Active and its File number is … a private company! Nemaura Medical Inc. ( NMRD ) stock -1.12 % ) Dec 24 2013! Ownership, revenue and average Growth rates Financials ; statistics ; Profile chart! Skin-Based drug delivery technologies delivery platform in 2011 over a decade of evidence... Over 20 years experience in the U.S. under the Jumpstart Our Business (... & personal training market is the CEO Dewan Fazlul Chowdhury with 42 % of outstanding... Its painless sugarbeat glucose monitor levels in patients with COVID-19 infection, insider trading, ownership, revenue average... Purposes and should be left unchanged UK based Medical technology company, discovers,,. Marker of critical disease states number is E0616432013-4 EIN for organizations is sometimes referred. Such as: Distance runners Triathletes Road cyclists Mountain bikers Spin training is listed as Active and File... Wireless non-invasive blood glucose tracking for improved Diabetes management … a private company! Lactate levels in patients with COVID-19 infection, 2013 is E0616432013-4, 3:07 PM % Dec! Temperature monitoring capabilities for several days at a time Joslin Institute lactic acid is a red medtech!